Journal of Gastroenterology

, 37:65

Hepatitis C virus superinfection in patients with chronic hepatitis B virus infection

  • Yun-Fan Liaw


Because hepatitis B virus (HBV) and hepatitis C virus (HCV) have the same transmission routes, dual infection may occur and even persist in the same patient. The reported series on seroprevalence of HCV indicate that HCV is found in more than 10% of HBV-infected patients worldwide. HCV superinfection in patients with chronic HBV infection tends to cause severe and progressive liver disease that is resistant to interferon therapy. Paradoxically, HCV exerts a suppressive effect on HBV and may enhance seroclearance of HBV antigens, or even usurp the role of HBV as the agent for continuing hepatitis. In view of the complex dynamism of viral interaction, the importance of HCV assay and the necessity of monitoring patients with chronic HBV infection in clinical studies cannot be overemphasized. The basic mechanisms that regulate the viral interactions largely remain to be investigated.

Key words

hepatitis B virus hepatitis C virus super-infection viral interference 


  1. 1.
    Alter HJ, Purcell RH, Shih WJ, Melpolder JC, Houghton M, Choo QL, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989;321:1494–500.PubMedGoogle Scholar
  2. 2.
    Genesca J, Esteban JI, Alter HJ. Blood borne non-A, non-B hepatitis: hepatitis C. Semin Liver Dis 1991;11:147–64.PubMedCrossRefGoogle Scholar
  3. 3.
    Liaw YF. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 1995;22:1101–8.PubMedGoogle Scholar
  4. 4.
    Liaw YF, Lin SM, Sheen IS, Chu CM. Acute hepatitis C virus superinfection followed by spontaneous HBeAg seroconversion and HBsAg elimination. Infection 1991;19:250-l.PubMedCrossRefGoogle Scholar
  5. 5.
    Troisi CL, Hollinger FB, Hoots WK, Contant C, Gill J, Ragni M, et al. A multicenter study of viral hepatitis in a United States hemophiliac population. Blood 1993;81:412–8.PubMedGoogle Scholar
  6. 6.
    Estaban JI, Estaban R, Viladomiu L, Lopez-Talavera JC, Gonzalez A, Hernandez JM, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989;ii:294–7.CrossRefGoogle Scholar
  7. 7.
    Liaw YF. Viral hepatitis in Taiwan: status in the 1990s. In: Nishioka K, Suzuki H, Mishiro S, Oda T, editors. Viral hepatitis and liver disease. Tokyo: Springer 1994;419–21.Google Scholar
  8. 8.
    Chu CM, Liaw YF, Pao CC, Huang MJ. The etiology of acute hepatitis superimposed upon previously unrecognized HBsAg carriers. Hepatology 1989;9:452–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Krogsgaard K, Wantzin P, Mathisen L, Ring-Larsen H, and the Copenhagen hepatitis acuta programme. Chronic evolution of acute hepatitis B: the significance of simultaneous infections with hepatitis C and D. Scand J Gastroenterol 1991;26:275–80.PubMedCrossRefGoogle Scholar
  10. 10.
    Bradley DW, Maynard JE, McCaustland KA, Murphy BL, Cook EH, Ebert JW. Non-A, non-B hepatitis in chimpanzees: interfer ence with acute hepatitis A virus and chronic hepatitis virus infec tion. J Med Virol 1983;11:207–13.PubMedCrossRefGoogle Scholar
  11. 11.
    Tsiquaye KN, Portmann B, Tovey G, Kessler H, Hu S, Lu X, et al. Non-A, non-B hepatitis in persistent carriers of hepatitis B virus. J Med Virol 1983;11:179–83.PubMedCrossRefGoogle Scholar
  12. 12.
    Fong TL, Di Bisceglie AM, Waggoner JG, Banks SM, Hoofnagle JH. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 1991;13:64–7.CrossRefGoogle Scholar
  13. 13.
    Sato S, Fujiyama S, Tanaka M, Yamasaki K, Kuramoto I, Kawano S, et al. Coinfection of hepatitis C virus in patients with chronic hepatitis B infection. J Hepatol 1994;21:159–66.PubMedCrossRefGoogle Scholar
  14. 14.
    Fattovich G, Tagger A, Brollo L, Giustina G, Pontisso P, Realli G, et al. Hepatitis C virus infection in chronic hepatitis B virus carriers. J Infect Dis 1991;163:400–2.PubMedGoogle Scholar
  15. 15.
    Crespo J, Lozano JL, de la Cruz F, Rodrigo L, Rodriguez M, San Miguel G, et al. Prevalence and significance of hepatitis C viremia in chronic active hepatitis B. Am J Gastroenterol 1994;89:1147–51.PubMedGoogle Scholar
  16. 16.
    Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, et al. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 1993;105: 1529–33.PubMedGoogle Scholar
  17. 17.
    Pontisso P, Gerotto M, Ruvoletto MG, Fattovich G, Chemello L, Tisminetzky S, et al. Hepatitis C genotypes in patients with dual hepatitis B and C virus infection. J Med Virol 1996;48:157–60.PubMedCrossRefGoogle Scholar
  18. 18.
    Chu CM, Yeh CT, Liaw YF. Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection. J Clin Micro 1998;36:2084–6.Google Scholar
  19. 19.
    Liaw YF, Tsai SL, Chang JJ, Sheen IS, Chien RN, Lin DY, et al. Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis. Gastroenterology 1994;106:1048–53.PubMedGoogle Scholar
  20. 20.
    Tsai SL, Liaw YF, Yeh CT, Chu CM, Kuo G. Cellular immune responses in patients with dual infections if hepatitis B and C viruses: dominant role of hepatitis C virus. Hepatology 1995;21: 908–12.PubMedGoogle Scholar
  21. 21.
    Sheen IS, Liaw YF, Chu CM, Pao CC. Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection. J Infect Dis 1992;165: 831–4.PubMedGoogle Scholar
  22. 22.
    Sheen IS, Liaw YF, Lin DY, Chu CM. Role of hepatitis C and delta viruses in the termination of chronic HBsAg carrier state: a multivariate analysis in a longitudinal follow-up study. J Infect Dis 1994;170:358–61.PubMedGoogle Scholar
  23. 23.
    Koike K, Yasuda K, Yotzuyanagi H, Moriya K, Hino K, Kurokawa K, et al. Dominant replication of either virus in dual infection with hepatitis viruses B and C. J Med Virol 1995;45:236–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Garcia-Samaniego J, Sariano V, Bravo R, González-Lahoz J, Múnoz F. Viral replication in patients with multiple hepatitis virus infections. Gastroenterology 1994;107:322–3.PubMedGoogle Scholar
  25. 25.
    Liaw YF, Tai DI, Chen TJ, Chu CM, Huang MJ. Alpha-fetoprotein changes in the course of chronic hepatitis: relation to bridging hepatic necrosis and hepatocellular carcinoma. Liver 1986;6:133–7.PubMedGoogle Scholar
  26. 26.
    Tandon BN, Irshad M, Acharya SK, Joshi YK. Hepatitis C virus infection is the major cause of severe liver disease in India. Gastroenterol Jpn 1991;26:S192–5.Google Scholar
  27. 27.
    Chu CM, Sheen IS, Liaw YF. The role of hepatitis C virus in fulminant viral hepatitis in an endemic area of hepatitis A and B. Gastroenterology 1994;107:189–95.PubMedGoogle Scholar
  28. 28.
    Wu JC, Chen CL, Hou MC, Chen TZ, Lee SD, Lo KJ. Multiple viral infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: application and limitation of the polymerase chain reaction. Hepatology 1994;19:836–40.PubMedGoogle Scholar
  29. 29.
    Colombari R, Dhillon AP, Piazzola E, Tomezzoli AA, Angelini GP, Gapra F, et al. Chronic hepatitis in multiple virus infection: histopathological evaluation. Histopathology 1993;22:319–25.PubMedCrossRefGoogle Scholar
  30. 30.
    Villa E, Grottola A, Buttafoco P, Trande P, Merighi A, Fratti N, et al. Evidence for hepatitis B virus infection in patients with chronic hepatitis C which and without serological markers of hepatitis B. Dig Dis Sci 1995;40:8–13.PubMedCrossRefGoogle Scholar
  31. 31.
    Liaw YF, Chien RN, Lin SM, Yeh CT, Tsai SL, Sheen IS, et al. Response of patients with dual hepatitis B virus and C virus infection to interferon therapy. J Interferon Cytokine Res 1997; 17:449–52.PubMedCrossRefGoogle Scholar
  32. 32.
    Huang CC, Liaw YF, Lai MK, Chu SH, Chuang CK, Huang JY. Clinical outcome of hepatitis C virus antibody-positive renal al lograft recipients. Transplantation 1992;53:763–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Yu MW, You SL, Chang AS, Lu SN, Liaw YF, Chen CI. Associa tion between hepatitis C virus antibodies and hepatocellular car cinoma in Taiwan. Cancer Res 1991;51:5621–5.PubMedGoogle Scholar
  34. 34.
    Kaklamani E, Trichopoulous D, Tzonou A, Zavitsanos X, Koumantaki Y, Hatzakis A, et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 1991;15:1974–6.CrossRefGoogle Scholar
  35. 35.
    Simonetti RG, Camma C, Fiorello F, Cottone M, Rapicetta M, Marino L, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case control study. Ann Intern Med 1992;116:97–102.PubMedGoogle Scholar
  36. 36.
    Yuki N, Hayashi N, Kasanara A, Hagiwara H, Katayama K, Fusamoto H, et al. Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carci noma. Dig Dis Sci 1992;37:65–72.PubMedCrossRefGoogle Scholar
  37. 37.
    Benvegnu L, Fottovich G, Noventa F, Tremoloda F, Chemello L, Cecchetto A, et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma. A prospective study. Cancer 1994;74:2442–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Sheu JC, Huang GT, Shih LN, Lee WC, Chou HC, Wang JT, et al. Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma. Gastroenterology 1992;103:1322–7.PubMedGoogle Scholar
  39. 39.
    Paterlini P, Driss F, Nalpas B, Pisi E, Franco D, Berthelot P, et al. Persistence of hepatitis B and C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low endemic area. Hepatology 1993;17:20–9.PubMedGoogle Scholar
  40. 40.
    Diamantis ID, McGandy CE, Chen TJ, Liaw YF, Gudat F, Bianchi L. Detection of hepatitis B and C viruses in liver tissue with hepatocellular carcinoma. J Hepatol 1994;20:405–9.PubMedCrossRefGoogle Scholar
  41. 41.
    Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Tsukamoto T, Hamba H, et al. Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma. Cancer 1999;86:793–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999;341:22–6.PubMedCrossRefGoogle Scholar
  43. 43.
    Shih CM, Lo SJ, Miyamura T, Chen SY, WuLee YH. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in Huh-7 cells. J Virol 1993;5823–32.Google Scholar
  44. 44.
    Gilles PN, Fey G, Chisari FV. Tumor necrosis factor alpha nega tively regulates hepatitis B virus gene expression in transgenic mice. J Virol 1992;66:3955–60.PubMedGoogle Scholar
  45. 45.
    González-Amaro R, Garcia-Monzón C, Garcia-Buey L, Moreno-Otero R, Alonso JL, Yagiie E, et al. Induction of tumor necrosis factor a production by human hepatocytes in chronic viral hepa titis. J Exp Med 1994;179:841–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2002

Authors and Affiliations

  • Yun-Fan Liaw
    • 1
  1. 1.Liver Research UnitChang Gung Memorial HospitalTaipeiTaiwan

Personalised recommendations